Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combining iPSC derived effector cell types for immunotherapy use

Combining iPSC derived effector cell types for immunotherapy use

US Patent 12275955 · Granted Apr 15, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunotherapies using enhanced iPSC derived effector cells2025
Immunotherapies using enhanced iPSC derived effector cells2025
Compositions and methods for immune cell modulation in adoptive immunotherapies2025
Compositions and methods for immune cell modulation in adoptive immunotherapies2025
Cell culture platform for single cell sorting and enhanced reprogramming of iPSC2025
Methods and compositions for inducing hematopoietic cell differentiation2025
Methods and compositions for inducing hematopoietic cell differentiation2025
Enhanced immune effector cells and use thereof2025
Enhanced immune effector cells and use thereof2025
Enhanced immune effector cells and use thereof2025
Methods and compositions for inducing hematopoietic cell differentiation2025
Platform for the induction and maintenance of ground state pluripotency2025